CVS vs CI
CVS and CI side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CVSCVS HEALTH CORPORATION | CIThe Cigna Group |
|---|---|---|
| Market cap | $115.47B | $72.92B |
| P/E (TTM) | 23.8 | 11.4 |
| P/B | 1.45 | 1.71 |
| P/S | 0.3x | 0.3x |
| Dividend yield | 2.94% | 2.21% |
| Revenue | $415.09B(TTM) | $282.38B(TTM) |
| Revenue growth (YoY) | 7.8% | 11.2% |
| Net income | $4.89B(TTM) | $6.42B(TTM) |
| Earnings growth (YoY) | -61.7% | 73.5% |
| EPS, diluted | $3.79(TTM) | $24.18(TTM) |
| EBIT margin | 1.2% | 3.3% |
| ROE | 2.2% | 14.0% |
| ROIC | 2.9% | 9.5% |
| Piotroski F | 6/9 | — |
| 1y total return | +25.6% | -4.9% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CVS frente a CI
| Métrica | CVS | CI |
|---|---|---|
| Valor final | $11.8K | $23.6K |
| Retorno total | +18.1% | +136.2% |
| CAGR | +1.6% | +8.7% |
| Volatilidad | 28.7% | 30.6% |
| Sharpe | 0.06 | 0.29 |
| Sortino | 0.08 | 0.41 |
| Caída máxima | -56.8% | -42.5% |
Basado en 2600 días de negociación comunes, 2016-05-16 → 2026-09-17 · tasa libre de riesgo 4.12% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)